Paul A. Volberding, M.D.
Professor of Medicine, University of California, San Francisco (UCSF)
Director, AIDS Research Institute
Director, amfAR Institute for HIV Cure Research
Co-Director, UCSF-GIVI Center for AIDS research and Associate Chair for Global Health, Department of Medicine

Locations:

• Geffen Auditorium (Live)
• Broadcast to SMH Alfred M-459 and MA 17-64
• Mayo Clinic Health System in Waycross (Video Conference)

Lunch available outside Geffen Auditorium and SMH Alfred M-459 on a first come, first serve basis

Learning Objectives:

• Describe the benefits of HIV therapy on life expectancy and economic productivity
• Describe the simplification of beginning HIV treatment on engagement in care
• Describe successfully HIB suppression blocks all routes of viral transmission
• Recognize the effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV acquisition
• Recognize the importance of identifying all cases of HIV infection in population-based programs to control the epidemic

Financial Disclosure:

• Merck - Consultant

Off Label/Investigational Uses:

• None

Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.